FDA inspection
Syngene International Ltd.: FDA inspection ending Aug 21, 2019
FDA inspection 1103377 · No Action Indicated (NAI) · Bengaluru
Key facts
| Inspection ID | 1103377 |
|---|---|
| Firm | Syngene International Ltd. |
| FEI number | 3003600340 |
| Address | Biocon Sez, Biocon Park, Plot No. 2, 3, 4 & 5, Bommasandra Industrial Park, Jigani Link Road |
| City | Bengaluru |
| Country | India |
| Fiscal year | 2019 |
| Inspection end date | Aug 21, 2019 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data